The North America Biobanking market size was valued at USD 1.1 billion in 2023, driven by an increase in research and development pharmaceuticals activities across the globe. The market size is anticipated to grow at a CAGR of 6.31% during the forecast period of 2024-2032 to achieve a value of USD 2 billion by 2032.
North America Biobanking Market: Introduction
The North America Biobanking Market is experiencing substantial growth, driven by the increasing recognition of biobanks as crucial resources for advancing medical research and developing personalized medicine. Biobanks collect, store, and manage biological samples like blood, tissue, and DNA, which are essential for studying disease mechanisms and developing treatments. The United States and Canada, with their advanced healthcare systems and robust research infrastructures, are at the forefront of this trend. This market is supported by significant investments in biotechnology and a strong regulatory framework that ensures sample quality and ethical compliance, setting a solid foundation for future innovations and discoveries in healthcare.
Get a Free Sample Report with a Table of Contents – https://www.expertmarketresearch.com/reports/north-america-biobanking-market/requestsample
Key Trends in the North America Biobanking Market
There is a growing emphasis on improving cryopreservation techniques and equipment to ensure the long-term viability and integrity of biological samples. Innovations in freezing methods and storage solutions are crucial for enhancing the quality of specimens and the reproducibility of research results.
Biobanks are increasingly adopting digital tools, including laboratory information management systems (LIMS) and big data analytics, to manage large volumes of data more efficiently. These technologies facilitate the tracking, analysis, and sharing of data, making it easier to derive valuable insights from stored samples.
The drive towards personalized medicine is a major factor boosting the biobanking market. Biobanks play a vital role in this field by providing researchers with access to diverse genetic materials that help in understanding individual variations in health, disease, and treatment responses.
As biobanking practices grow, so do concerns regarding ethics, privacy, and consent. There is an increasing focus on developing stringent guidelines and policies to address these issues, ensuring the ethical management of biobank resources and the protection of donor rights.
Strategic partnerships between biobanks, academic institutions, healthcare providers, and industry players are becoming more common. These collaborations enhance resource sharing, funding opportunities, and the commercialization of research findings, leading to accelerated advancements in medical research and development.
The application of biobank samples in regenerative medicine and cell therapy is expanding. These fields rely on high-quality tissue and cell samples for developing therapies aimed at restoring or establishing normal function in damaged tissues or organs.
There is an increase in the establishment of large-scale population-based biobanks in North America, which aim to collect data from diverse population groups. These biobanks are valuable for epidemiological studies and help in understanding how genetic and environmental factors influence health and disease across different demographics.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/north-america-biobanking-market
North America Biobanking Market Segmentation
Market Breakup by Equipment
- Cryogenic Storage Systems
- Alarm Monitoring Systems
- Others
Market Breakup by Media
- Optimized Media
- Non-Optimized Media
- Others
Market Breakup by Services
- Human Tissue Biobanking
- Stem Cell Biobanking
- Cord Banking
- DNA/RNA Biobanking
- Others
Market Breakup by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Others
Market Breakup by Application
- Drug Discovery
- Disease Research
- Others
Market Breakup by End User
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Others
Market Breakup by Country
- United States of America
- Canada
North America Biobanking Market Overview
The United States is a leader in the North American biobanking market, bolstered by its advanced biomedical research infrastructure, substantial healthcare investments, and a strong network of academic and corporate partnerships. The U.S. is home to numerous leading research institutions and universities that heavily integrate biobanking in their research, particularly for cancer research, genetic studies, and personalized medicine.
Significant public and private funding boosts the U.S. biobanking sector, with major contributions from the National Institutes of Health (NIH) and various private foundations that support biomedical research. The U.S. has comprehensive regulations governing biobanking, which ensure ethical practices and the protection of personal data, thereby enhancing public trust and participation Canada’s biobanking market, while smaller than the U.S., is characterized by high-quality research and a collaborative approach to biobanking.
National and Canada benefit from a series of well-organized national and provincial biobanks that support various large-scale health studies, particularly in areas like population health and disease-specific research.
The Canadian government, through entities such as the Canadian Institutes of Health Research (CIHR), provides substantial support for biobanking, emphasizing the importance of these resources for advancing healthcare and medical research.
Canadian biobanks often participate in international biobanking consortia, enhancing their capabilities through shared knowledge, standards, and technologies. This collaboration extends to public-private partnerships that are vital for innovation and commercialization of research findings.
North America Biobanking Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Atlanta Biologicals Inc. (Bio-Techne Corporation)
Atlanta Biologicals Inc., a subsidiary of Bio-Techne Corporation, is a prominent player in the life sciences sector, known for supplying high-quality cell culture sera and reagents. Their products are critical for biomedical research, particularly in applications involving cell growth, detection, and contamination prevention. Atlanta Biologicals’ reputation for reliability and product excellence helps researchers and institutions achieve reproducible results. Since being acquired by Bio-Techne Corporation, a leader in developing high-performance tools and instruments for biological research, Atlanta Biologicals has expanded its reach and capabilities, enhancing its offerings to meet the evolving demands of the scientific community.
- Becton, Dickinson and Company (BD)
Becton, Dickinson and Company (BD) is a global medical technology company headquartered in Franklin Lakes, New Jersey. Founded in 1897, BD has become a leading provider in medical supplies, devices, laboratory equipment, and diagnostic products. Serving healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry, BD focuses on enhancing drug delivery, improving the diagnosis of infectious diseases and cancers, and advancing drug discovery. The company’s commitment to safety and efficiency in healthcare is evident through its innovative product lines and active role in developing new healthcare solutions. BD operates in nearly 50 countries and employs approximately 70,000 people worldwide.
- BioLife Solutions
BioLife Solutions is a leading developer, manufacturer, and supplier of bioproduction tools and services for the cell and gene therapy markets. Headquartered in Bothell, Washington, the company specializes in cryopreservation and cell thawing solutions that enhance the quality, viability, and yield of biological materials. BioLife Solutions offers a suite of proprietary products, including HypoThermosol® and CryoStor®, which are designed to optimize the storage and transport conditions of cell and gene therapies. With its focus on innovation and quality, BioLife Solutions is committed to supporting the advancement of science in biobanking, regenerative medicine, and clinical applications globally.
- Chart Industries
Chart Industries, Inc. is a leading global manufacturer of highly engineered equipment servicing multiple applications in the Energy and Industrial Gas markets. Headquartered in Atlanta, Georgia, the company specializes in the design and production of cryogenic equipment used in the production, storage, and distribution of liquefied gases such as oxygen, nitrogen, argon, and natural gas. Chart Industries plays a pivotal role in the clean energy transition by providing technology and systems for the liquefaction, storage, and distribution of hydrogen and LNG. Their products are integral to various sectors including energy, biomedical, and commercial food refrigeration.
- Hamilton Company
Hamilton Company, established in 1953, pioneers precision fluid measuring instruments and laboratory automation technology. Specializing in liquid handling, robotics, and automated sample storage, Hamilton serves diverse industries including healthcare, life sciences, and chemistry. Their innovations enable precise, efficient, and reliable processes in research, diagnostics, and drug discovery. Renowned for quality and reliability, Hamilton’s products range from pipettes and syringes to complex robotic workstations. Their solutions streamline workflows, enhance productivity, and ensure reproducibility in laboratories worldwide, contributing significantly to scientific advancements and breakthroughs.
Read More Report:
India Disposable Catheters Market – https://www.expertmarketresearch.com/reports/india-disposable-catheters-market
Europe Compression Bandages Market – https://www.expertmarketresearch.com/reports/europe-compression-bandages-market
Peptide Therapeutics Market – https://www.expertmarketresearch.com/reports/peptide-therapeutics-market
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Hester Laurier, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
